p53 family interactions and yeast: together in anticancer therapy

被引：11

作者：

Gomes, Sara ^{[1
]}

Leao, Mariana ^{[1
]}

Raimundo, Liliana ^{[1
]}

Ramos, Helena ^{[1
]}

Soares, Joana ^{[1
]}

Saraiva, Lucilia ^{[1
]}

机构：

[1] Univ Porto, Dept Ciencias Biol, Microbiol Lab, UCIBIO REQUIMTE,Fac Farm, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal

来源：

DRUG DISCOVERY TODAY | 2016年 / 21卷 / 04期

关键词：

WILD-TYPE P53; MUTANT P53; FUNCTIONAL ASSAY; TRANSCRIPTIONAL ACTIVITY; P53-MDM2; INTERACTION; MDM2; ONCOPROTEIN; 2-HYBRID SYSTEM; CANCER-THERAPY; P73; FUNCTION; IN-VITRO;

D O I：

10.1016/j.drudis.2016.02.007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The p53 family proteins are among the most appealing targets for cancer therapy. A deeper understanding of the complex interplay that these proteins establish with murine double minute (MDM)2, MDMX, and mutant p53 could reveal new exciting therapeutic opportunities in cancer treatment. Here, we summarize the most relevant advances in the biology of p53 family protein-protein interactions (PPIs), and the latest pharmacological developments achieved from targeting these interactions. We also highlight the remarkable contributions of yeast-based assays to this research. Collectively, we emphasize promising strategies, based on the inhibition of p53 family PPIs, which have expedited anticancer drug development.

引用

页码：616 / 624

页数：9

共 50 条

[11] IMPACT OF P53 MODULATION ON INTERACTIONS BETWEEN P53 FAMILY MEMBERS DURING HACAT KERATINOCYTES DIFFERENTIATION
Rusanov, A. L.
Kozhin, P. M.
Romashin, D. D.
Karagyaur, M. N.
Luzgina, N. G.
BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2020, (06): : 58 - 65
[12] Regulation of p53 and p53 family members.
Prives, C
Ahn, J
DiComo, C
Gaiddon, C
Shieh, S
FASEB JOURNAL, 1999, 13 (07): : A1430 - A1430
[13] Anticancer drugs - Unleashing p53
Kirkpatrick, P
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (02) : 111 - 111
[14] P53 gene: major mutations in neoplasias and anticancer gene therapy
de Oliveira Lima, Caroline Rocha
Rabelo, Rogerio Elias
Scalla Vulcani, Valcinir Aloisio
Cardoso, Lorena Damasio
de Moura Sousa, Nicaelle Luan
Brianezi Dignani de Moura, Veridiana Maria
CIENCIA RURAL, 2012, 42 (05): : 845 - 853
[15] Influence of anticancer drugs on interactions of tumor suppressor protein p53 with DNA
Pivonkova, H
Nemcova, K
Brazdova, M
Kasparkova, J
Brabec, V
Fojta, M
FEBS JOURNAL, 2005, 272 : 562 - 562
[16] Deciphering the Interactions between an Anticancer Bacteriocin and the P53 DNA Binding Domain
Huang, Yongqi
Zhou, Jingjing
Cheng, Xiyao
Su, Zhengding
BIOPHYSICAL JOURNAL, 2018, 114 (03) : 222A - 222A
[17] All in the p53 family
Kristine Novak
Nature Medicine, 1998, 4 (7) : 771 - 771
[18] The p53 gene family
William G Kaelin
Oncogene, 1999, 18 : 7701 - 7705
[19] p53 family in development
Danilova, Nadia
Sakamoto, Kathleen M.
Lin, Shuo
MECHANISMS OF DEVELOPMENT, 2008, 125 (11-12) : 919 - 931
[20] p53, a family guardian
Gilgenkrantz, S
M S-MEDECINE SCIENCES, 1996, 12 (10): : 1116 - 1117

← 1 2 3 4 5 →